MedTrace Logo

Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis

NCT04775225 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-01-17

No results posted yet for this study

Summary

Patients having juvenile idiopathic arthritis (according to ILAR criteria) with hip arthritis were divided into 3 groups. Group 1 received hip denervation and group 2 controlled and received a subcutaneous injection of saline, and group 3 received intra-articular triamcinolone. Outcome measures included pain, tenderness, range of motion, SOLAR, HARISS score. These outcomes were measured at baseline, 2 weeks, and 16 weeks

Conditions

  • Juvenile Idiopathic Arthritis
  • Hip Arthritis

Interventions

DRUG

Lidocaine

denervation of the obturator and femoral genicular branches by Lidocaine 2 %

DRUG

Placebo

an equivalent amount of saline will be injected subcutaneously in 2 points similar to the active group

DRUG

Steroid

Intra-articular injection of 80mg of triamcinolone

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-06
Primary Completion
2021-04-06
Completion
2021-04-06

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04775225 on ClinicalTrials.gov